Safety and Efficacy Study of a Eye Drop for Eye Allergy

NCT00889330 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Conjunctivitis

Interventions

DRUG: alcaftadine
DRUG: Placebo

Sponsor

Vistakon Pharmaceuticals